Suchergebnisse - "Nakamura, Mai"

PubPharm (85)

1

Pancreaticoduodenectomy after bilirubin adsorption for distal cholangiocarcinoma with severe obstructive jaundice refractory to repeat preoperative endoscopic biliary drainage : a case report

enthalten in: Clinical journal of gastroenterology | 2024

von Nakayama, T. | Ito, K. | Nakamura, M. | +6

2

A unique case of a typical pancreatic ductal adenocarcinoma that initially presented with a cystic component but underwent morphological changes

enthalten in: Clinical journal of gastroenterology | 2024

von Nabeshima, Y. | Takemura, N. | Mihara, F. | +5

3

In vivo evidence for homeostatic regulation of ribosomal protein levels in Drosophila

enthalten in: Cell structure and function | 2024

von Kitamura, D. | Taniguchi, K. | Nakamura, M. | +1

4

Using Indocyanine Green Fluorescence Imaging to Identify an Anomalous Cystohepatic Duct During Laparoscopic Cholecystectomy

enthalten in: The American surgeon | 2023

von Oikawa, R. | Ito, K. | Takemura, N. | +5

5

A deazariboflavin chromophore kinetically stabilizes reduced FAD state in a bifunctional cryptochrome

enthalten in: Scientific reports | 2023

von Hosokawa, Y. | Morita, H. | Nakamura, M. | +1

6

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS ASSOCIATED WITH NEURODEGENERATIVE DISEASE OR IMPULSIVE SYMPTOMS ASSOCIATED WITH MENTAL DISEASE CONTAINING BREXPIPRAZOLE OR SALT THEREOF

enthalten in: Europäisches Patentamt | 2023

von SATO SHINJI | MAEDA KENJI | ISHIKAWA MASARU | +1

7

Multivisceral resection for primary pancreatic signet ring cell carcinoma

enthalten in: Clinical journal of gastroenterology | 2023

von Nakamura, M. | Inagaki, F. | Takemura, N. | +4

8

Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders

enthalten in: Europäisches Patentamt | 2023

von MAEDA KENJI | NAKAMURA MAI

9

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS ASSOCIATED WITH NEURODEGENERATIVE DISEASE OR IMPULSIVE SYMPTOMS ASSOCIATED WITH MENTAL DISEASE CONTAINING BREXPIPRAZOLE OR SALT THEREOF

enthalten in: Europäisches Patentamt | 2022

von SATO SHINJI | MAEDA KENJI | ISHIKAWA DAI | +1

10

PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS ASSOCIATED WITH NEURODEGENERATIVE DISEASE OR IMPULSIVE SYMPTOMS ASSOCIATED WITH MENTAL DISEASE CONTAINING BREXPIPRAZOLE OR SALT THEREOF

enthalten in: Europäisches Patentamt | 2022

von SATO SHINJI | MAEDA KENJI | ISHIKAWA DAI | +1

1
2
3
4
5
6
7
8
9
Nächster »
[9]